FRESH Study (Fitness, Relaxation and Eating to Stay Healthy) (FRESH)

May 6, 2022 updated by: Linda Libertini, The Cleveland Clinic

Diet, Exercise, Cooking, and Stress Management for Patients With Prediabetes: A Pilot Randomized Controlled Study

To examine whether a lifestyle program results in weight loss and thereby delays or prevents progression of pre-diabetes to diabetes, we propose a pilot randomized controlled trial of 6 weeks duration with 30 participants held at Stephanie Tubbs Jones Health Center. Participants are randomized to receive all of the following: nutrition education, exercise instruction, stress management instruction, and culinary education or follow usual care. Outcomes include: blood sugars and cholesterol, weight, waist circumference, blood pressure, diet, physical activity, perceived stress, and class attendance. Analysis is by Intention to treat analysis of variance. Results will be used to help design larger randomized trial in the future.

Study Overview

Detailed Description

Control group:

These participants will continue to receive their usual care from their primary medical care team.

Intervention group:

The participants will receive nutrition education, exercise instruction, stress management instruction,and culinary education

Study Type

Interventional

Enrollment (Actual)

27

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • East Cleveland, Ohio, United States, 44112
        • Stephanie Tubbs Jones Health Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Study participants must:

    1. Be capable of giving informed consent
    2. Understand and voluntarily sign the informed consent form.
    3. Be females at least 18 years of age and identify themselves as African-American
    4. Have prediabetes as defined by the American Diabetes Association: history of glycated hemoglobin (HgbA1c) 5.7-6.4 % or fasting blood glucose 100-125 mg/dL (5.6-6.9 mmol/L) (fasting defined as no caloric intake for at least 8 hours), or a 2-hour plasma glucose 140-199 mg/dL (7.8-11.0 mmol/L) during an oral glucose tolerance test (as described by the World Health Organization using a glucose load of 75 g anhydrous glucose dissolved in water)
    5. Have a body mass index (BMI, defined as weight in kilograms divided by height in meters squared) greater than or equal to 25

Exclusion Criteria:

  1. Current or previous diagnosis of diabetes or a history of HgbA1c ≥ 6.5% or fasting blood glucose ≥ 126 mg/dL (7.0 mmol/L) (fasting defined as no caloric intake for at least 8 hours), or a 2-hour plasma glucose ≥ 200 mg/dL (11.1 mmol/L) during an oral glucose tolerance test or a history of classic symptoms of hyperglycemia or hyperglycemic crisis and a random plasma glucose ≥ 200 mg/dL (11.1 mmol/L).
  2. Normal glycemia or a currently with a HgbA1c < 5.7% or fasting blood glucose < 100 mg/dL (7.0 mmol/L) (fasting defined as no caloric intake for at least 8 hours), or a 2-hour plasma glucose < 140 mg/dL (11.1 mmol/L) during an oral glucose tolerance test
  3. Current or past use of oral hypoglycemic agents (including, but not limited to, metformin, rosiglitazone, pioglitazone, glipizide, and glyburide) or insulin
  4. Male gender
  5. History of congestive heart failure
  6. History of renal failure, dialysis, or creatinine greater than 2 mg/dL
  7. History of liver failure or a liver dysfunction with a increase by a factor of 2 above the upper limit of normal in alanine aminotransferase or aspartate aminotransferase
  8. History of gastrointestinal disorder that would prevent adherence to the recommended diet (e.g. celiac disease, inflammatory bowel disease, history of bariatric surgery, history of intestinal surgery)
  9. Presence of active cancer
  10. History of coronary artery disease or cerebrovascular disease
  11. History of uncontrolled hypertension
  12. Participation in another lifestyle modification trial
  13. Pregnancy or lactating or planning to be pregnant
  14. Current alcoholism or abuse of recreational drugs
  15. Hospitalization for depression in past 12 months
  16. Travel plans that do not permit full participation or participant lives too far from Health Center to permit full participation
  17. History of bariatric surgery, small bowel resection, or extensive bowel resection
  18. Chronic treatment with systemic steroids
  19. Current diagnosis of schizophrenia, other psychotic disorders, or bipolar disorder
  20. Inability to walk two blocks
  21. Other medial, psychiatric, or behavioral limitations that in the judgment of the principal investigator may interfere with study participation or the ability to follow the intervention protocol
  22. Amputation of lower limb for nontraumatic causes
  23. Self report of HIV-positivity or active tuberculosis
  24. Documented history of pulmonary embolus in past six months
  25. Chronic obstructive pulmonary disease that would limit ability to follow the study protocol
  26. Self-reported chronic hepatitis B or C or cirrhosis; inflammatory bowel disease requiring treatment in past year; Cushing's syndrome; acromegaly (clinical diagnosis or self-report); any major organ transplant
  27. Unwilling or uninterested in participating in group lifestyle education sessions
  28. Current regular corticosteroid use
  29. Active polycystic ovarian syndrome

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Arm A: Control group
These participants will continue to receive their usual care from their primary medical care team.
Experimental: Arm B
Arm includes diet instruction, exercise, stress management, and culinary education
Every other week
Every other week
Every week
Every other week

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of "FRESH" Program on Weight Loss
Time Frame: Baseline line and final followup visit (at 8-14 weeks)
Change in weight measured at baseline and followup (at 8-14 weeks).
Baseline line and final followup visit (at 8-14 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diet - Daily Calorie Intake
Time Frame: Baseline and final followup visit (at 8-14 weeks)
Change in daily caloric intake as measured by online 24-hour recall dietary program
Baseline and final followup visit (at 8-14 weeks)
Exercise
Time Frame: Baseline and final followup visits (at 8-14 weeks)
Change in 7-day average steps/day as measured by pedometer at baseline and followup (at 8-14 weeks).
Baseline and final followup visits (at 8-14 weeks)
Stress
Time Frame: baseline and followup visit (at 8-14 weeks)
Change of Psychosocial Stress (PSS-10) scores (total range 0-40) measured at baseline and followup (at 8-14 weeks). Higher score reflects worse outcome.
baseline and followup visit (at 8-14 weeks)
Sleep
Time Frame: baseline and followup visit (at 8-14 weeks)
Change in self-reported average hours of sleep/night measured at baseline and followup (at 8-14 weeks).
baseline and followup visit (at 8-14 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adam M Bernstein, M.D., The Cleveland Clinic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2012

Primary Completion (Actual)

October 1, 2012

Study Completion (Actual)

December 1, 2012

Study Registration Dates

First Submitted

July 5, 2012

First Submitted That Met QC Criteria

July 5, 2012

First Posted (Estimate)

July 10, 2012

Study Record Updates

Last Update Posted (Actual)

May 10, 2022

Last Update Submitted That Met QC Criteria

May 6, 2022

Last Verified

May 1, 2022

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight

Clinical Trials on Stress Management

Subscribe